Retinoid-induced expression and activity of an immediate early tumor suppressor gene in vascular smooth muscle cells

Jeffrey W Streb1, Xiaochun Long, Ting-Hein Lee

  • 1Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.

Plos One
|April 13, 2011
PubMed

Insights

Retinoids rapidly increase A-Kinase Anchoring Protein 12 beta (AKAP12β) expression, a tumor suppressor that inhibits vascular smooth muscle cell growth. This reveals a new mechanism for retinoid action in preventing vascular diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Vascular Biology

Background:

  • Retinoids are clinically used for hyper-proliferative disorders.
  • Retinoids experimentally attenuate vascular occlusive diseases.
  • Retinoid action is mediated through retinoic acid response elements (RAREs).

Purpose of the Study:

  • To investigate the molecular mechanisms of retinoid action in vascular smooth muscle cells (SMC).
  • To identify novel retinoid-induced genes involved in vascular health.
  • To explore the role of AKAP12β in retinoid-mediated anti-proliferative effects.

Main Methods:

  • Studied retinoid induction of AKAP12β mRNA and protein in cultured SMC and intact vessel walls.
  • Performed expression kinetics and actinomycin D studies to determine gene regulation.
  • Analyzed Akap12β promoter for RAREs and used immunofluorescence microscopy and PKA overlay assays.
  • Assessed SMC growth in vitro and AKAP12 expression in experimentally-injured mouse vessels and human atheromatous lesions.

Main Results:

  • Retinoids rapidly induce AKAP12β mRNA and protein expression in SMC and vessel walls.
  • Akap12β is a retinoid-induced, immediate-early gene with a conserved RARE in its promoter.
  • AKAP12β physically associates with protein kinase A (PKA) and attenuates SMC growth.
  • AKAP12 expression is decreased in injured vessels and human atherosclerotic lesions.

Conclusions:

  • Retinoids induce the tumor suppressor AKAP12β, which inhibits vascular SMC proliferation.
  • This identifies a novel retinoid-induced pathway targeting vascular SMC growth.
  • Provides molecular insight into retinoid's anti-proliferative effects in the injured vessel wall.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...